Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
jcm-logo

Journal Browser

Journal Browser

Current Perspectives and Emerging Insights in Urological Cancer

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: 20 October 2026 | Viewed by 10

Special Issue Editors


E-Mail
Guest Editor
Third Department of Urology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece
Interests: prostate cancer; prostate biopsies; bladder cancer; urogenital cancer
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
First Department of Urology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
Interests: prostate cancer; prostate biopsies; bladder cancer; urogenital cancer

Special Issue Information

Dear Colleagues,

Urological malignancies, including prostate, bladder, renal, testicular and upper tract urothelial cancer, remain a leading cause of morbidity and mortality worldwide. Incidence patterns are shifting with aging populations and changing exposures, while advances in molecular profiling, immuno-oncology, radiologic diagnostics and minimally invasive techniques are rapidly altering clinical paradigms. Accurate early detection, with fusion MRI/US prostate biopsies, robust predictive biomarkers, the management of treatment resistance and equitable access to precision therapies underscore the imperative for rigorous, multidisciplinary research that can be translated into improved outcomes at population and individual levels.

Concurrently, the field is poised for transformative progress: high-throughput genomics and liquid biopsy enable dynamic disease characterization; novel systemic agents and combination strategies are expanding therapeutic options and refined imaging and surgical technologies permit more personalized, organ-preserving approaches. This Special Issue convenes cutting-edge investigations that address these timely challenges and opportunities, with emphasis on studies that have clear implications for clinical practice, guideline development or health policies.

This Special Issue aims to present and disseminate the most recent, highest-quality advances in the biology, diagnosis, management and survivorship of urological cancers. We welcome contributions that rigorously evaluate molecular mechanisms, diagnostic and prognostic biomarkers, novel therapeutic and diagnostic strategies and health-system-level interventions, particularly those with reproducible methods, robust clinical endpoints and direct translational relevance.

Dr. Ilias Giannakodimos
Dr. Konstantinos Stravodimos
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prostate cancer
  • renal cancer
  • bladder cancer
  • urogenital cancer
  • urological cancer
  • biopsy
  • diagnosis
  • therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop